A Billionaire’s Final Gift to Six U.S. Cancer Centers

first_imgA trust fund created by billionaire shipping tycoon Daniel K. Ludwig ends today with a bang and a gift to research. Six U.S. medical centers will receive $540 million—$90 million each—from the fund to endow cancer studies in perpetuity, or until cancer is no longer a problem, as specified in the will left by Ludwig, who died in 1992. In all, his estate has given $2.5 billion to cancer research since the 1970s.The new money goes to Ludwig Centers already located at six elite research institutions: Harvard Medical School in Boston; Johns Hopkins University in Baltimore, Maryland; the Massachusetts Institute of Technology in Cambridge; the Memorial Sloan-Kettering Cancer Center in New York City; Stanford University in Palo Alto; and the University of Chicago. The Ludwig trust had established the same centers in 2006.The funding by the Ludwig trust has been “sort of under the radar,” says oncologist Kenneth Kinzler, who, along with Bert Vogelstein, co-directs the Ludwig Center at Hopkins. These are among the most coveted awards in biomedicine, Kinzler says. The money is held as an endowment and comes with few strings attached—just a mandate to investigate cancer and find ways to stop it. There are no progress reports or renewal applications to write, Kinzler says, which “allows you to focus on what you think will yield the most important results without being concerned about meeting artificial intermediate deadlines.”Sign up for our daily newsletterGet more great content like this delivered right to you!Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of theCook IslandsCosta RicaCote D’IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People’s Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexicoMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalestinianPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarReunionRomaniaRussian FederationRWANDASaint Barthélemy Saint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweI also wish to receive emails from AAAS/Science and Science advertisers, including information on products, services and special offers which may include but are not limited to news, careers information & upcoming events.Required fields are included by an asterisk(*)The Ludwig group seeks clinical outcomes, Kinzler says, a goal that he and Vogelstein strongly endorse. Without the Ludwig money, the Hopkins group would not have been able to do the cancer genetics studies they’re famous for, he notes—for example, the duo has used exome surveys to identify genes associated with colon and breast cancers.The sheer size of the Ludwig endowments makes a difference, says cancer immunologist Jedd Wolchok at Memorial Sloan-Kettering: “It allows for a respectable research budget.” Wolchok figures that his group’s budget for cancer immunology research will double this year, rising by “several million dollars,” and likely will continue to grow, thanks to the money earned by the endowment. For Wolchok, that means that “we can go from concept to clinical investigation very, very quickly.” For example, he expects his group to launch a clinical trial in 2 months to test a therapeutic antibody developed by a Japanese company that could be used to modulate T cells that regulate the immune response. The Memorial Sloan-Kettering team also has a series of clinical trials under way to monitor immune system reactions to various cancer therapies, including radiation.Ludwig, a friend of President Richard Nixon, was a stalwart backer of Nixon’s “War on Cancer,” which was linked to the congressional legislation that reestablished the U.S. National Cancer Institute in 1971. That year, the shipping magnate created an independent outfit in New York City, the Ludwig Institute for Cancer Research. The organization now has an endowment of more than $1.2 billion and employs more than 600 people, including scientists in six countries outside the United States, according to institute CEO Edward McDermott Jr.The philosophy that drives this research network, McDermott says, is the one that drove Ludwig “in his personal business enterprises—to find the best people and resource them well.” McDermott adds: “We invest in scientists, not particular science.  … We are not in the business of discovery for discovery’s sake. It’s a means to an end, which is improved patient outcomes. So we are very committed to … infrastructures that allow us to take our discoveries from bench to bedside.” McDermott says that the institute has sponsored more than 100 clinical trials and has eight under way right now. All of these focus on cancer immunotherapy.last_img read more

​Newcastle go all out to capture Chinese supporters

first_imgNewcastle United has launched three new social media accounts in China as part of the club’s 125th anniversary celebrations, reports www.fcbusiness.co.ukThe club has unveiled official accounts on Sina Weibo, WeChat and Dongqiudi platforms, in an attempt to boost communications and engagement with millions of sports fans across the Far East.They have been named as the fastest growing football club brand in the world in 2017 by industry experts Brand Finance, with 92% growth in the last 12 months.Lee Charnley, managing director at Newcastle United, said: “Social media plays a hugely important role in how we engage with supporters, particularly those who are unable to be close to St. James’ Park, so we are pleased to be launching new accounts on Sina Weibo, WeChat and Dongqiudi.”With a number of existing fan groups in China and a growing presence in the region, both as a Premier League club and now as a partner of FUN88, this is a natural step for us and we look forward to connecting with even more fans and sharing our experiences with them.”Micro-blogging site Sina Weibo is one of the most visited websites in China; with well over half a billion registered users. It is widely regarded as hybrid of Western social media platforms Facebook and Twitter.The Magpies’ ‘Weibo’ account will feature a variety of bespoke content, including the best images, video and digital content from the Magpies throughout the 2017/18 Premier League season and beyond.WeChat is a dynamic micro-messaging app with more than 900m active users – around 90% of whom are based in China.Newcastle United’s official WeChat account will provide subscribers with a packed feed of the latest news and updates from the club, as well as the use of unique player-based sticker emojis and the potential for a number of additional services.Dongqiudi, meanwhile, is a popular football-specific social networking app that was established in 2013. The app enables supporters in China to join their own online club community, getting closer to the team despite following from afar.The three new accounts add to Newcastle United’s growing social media portfolio, with a presence on Twitter, Facebook, Instagram, Snapchat (search: nufcofficial) and YouTube – generating a combined following of almost 3.5m people.last_img read more